Literature DB >> 18078706

Urocortin and the brain.

Weihong Pan1, Abba J Kastin.   

Abstract

Urocortin is a member of the corticotropin-releasing hormone (CRH) family of peptides. In the brain, its potent suppression of food intake is mediated by CRH receptors (CRHR). Urocortin also participates in the regulation of anxiety, learning, memory, and body temperature, and it shows neuroprotection. This review will summarize the location of urocortin-producing neurons and their projections, the pharmacological evidence of its actions in the CNS, and information acquired from knockout mice. Urocortin interacts with leptin, neuropeptide Y, orexin, and corticotropin in the brain. Also produced by the GI tract, heart, and immune cells, urocortin has blood concentrations ranging from 13 to 152 pg/ml. Blood-borne urocortin stimulates the cerebral endothelial cells composing the blood-brain barrier and crosses the blood-brain barrier by a unique transport system. Overall, urocortin acts on a broad neuronal substrate as a neuromodulator important for basic survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078706      PMCID: PMC2267723          DOI: 10.1016/j.pneurobio.2007.10.008

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  93 in total

Review 1.  Urocortins in human reproduction.

Authors:  Pasquale Florio; Wylie Vale; Felice Petraglia
Journal:  Peptides       Date:  2004-10       Impact factor: 3.750

2.  Isolation and amino acid composition of sauvagine. An active polypeptide from methanol extracts of the skin of the South American frog Phyllomedusa sauvagei.

Authors:  P C Montecucchi; A Anastasi; R de Castiglione; V Erspamer
Journal:  Int J Pept Protein Res       Date:  1980-09

Review 3.  Misleading concepts in the field of brain peptides.

Authors:  A J Kastin; J E Zadina; W A Banks; M V Graf
Journal:  Peptides       Date:  1984       Impact factor: 3.750

Review 4.  The brain-gut-skin triangle: new peptides.

Authors:  V Erspamer; P Melchiorri; M Broccardo; G F Erspamer; P Falaschi; G Improota; L Negri; T Renda
Journal:  Peptides       Date:  1981       Impact factor: 3.750

5.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

6.  Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

Authors:  M Spina; E Merlo-Pich; R K Chan; A M Basso; J Rivier; W Vale; G F Koob
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

7.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.

Authors:  J Vaughan; C Donaldson; J Bittencourt; M H Perrin; K Lewis; S Sutton; R Chan; A V Turnbull; D Lovejoy; C Rivier
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

Review 8.  Localization and physiological roles of urocortin.

Authors:  Yutaka Oki; Hironobu Sasano
Journal:  Peptides       Date:  2004-10       Impact factor: 3.750

9.  Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.

Authors:  K Lederis; A Letter; D McMaster; G Moore; D Schlesinger
Journal:  Science       Date:  1982-10-08       Impact factor: 47.728

10.  Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

Authors:  J M Martins; A J Kastin; W A Banks
Journal:  Neuroendocrinology       Date:  1996-04       Impact factor: 4.914

View more
  25 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor.

Authors:  Yu Ohmura; Takeshi Izumi; Taku Yamaguchi; Iku Tsutsui-Kimura; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

4.  Leptin signaling modulates the activity of urocortin 1 neurons in the mouse nonpreganglionic Edinger-Westphal nucleus.

Authors:  Lu Xu; Wim J J M Scheenen; Rebecca L Leshan; Christa M Patterson; Carol F Elias; Sanne Bouwhuis; Eric Willem Roubos; Martin G Myers; Tamás Kozicz
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

5.  The effect of long-term ovariectomy on midbrain stress systems in free ranging macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy
Journal:  Brain Res       Date:  2012-10-01       Impact factor: 3.252

Review 6.  Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms.

Authors:  T A Roepke
Journal:  J Neuroendocrinol       Date:  2008-12-06       Impact factor: 3.627

Review 7.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

Review 8.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

9.  Orexin-A inputs onto visuomotor cell groups in the monkey brainstem.

Authors:  S Schreyer; J A Büttner-Ennever; X Tang; M J Mustari; A K E Horn
Journal:  Neuroscience       Date:  2009-08-22       Impact factor: 3.590

Review 10.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.